Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Cytokine responses to Staphylococcus aureusbloodstream infection differ between patient cohorts that have different clinical courses of infection

Authors: Sinead McNicholas, Alida Fe Talento, Joanne O’Gorman, Margaret M Hannan, Maureen Lynch, Catherine M Greene, Hilary Humphreys, Deirdre Fitzgerald-Hughes

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

The clinical course of Staphylococcus aureus bloodstream infection is unpredictable and bacterial virulence, host immune response and patient characteristics are among the factors that contribute to the clinical course of infection. To investigate the relationship between cytokine response and clinical outcome, circulating cytokine levels were investigated in response to S. aureus bloodstream infection in patients with different clinical courses of infection.

Methods

A prospective study was carried out in 61 patients with S. aureus bloodstream infection and circulating levels of IL-6, GRO-γ, RANTES and leptin were assessed over the course of the infection. Levels were compared in patients with complicated courses of infection (e.g. infective endocarditis) versus uncomplicated courses of S. aureus bloodstream infection and methicillin-resistant S. aureus Vs methicillin-susceptible S. aureus infection.

Results

Significantly lower leptin levels (p < 0.05) and significantly higher IL-6 levels (p < 0.05) were detected at laboratory diagnosis in patients with complicated compared to uncomplicated S. aureus bloodstream infection. Significantly higher levels of GRO-γ were associated with MRSA infection compared to MSSA infection.

Conclusions

IL-6 may be an early inflammatory marker of complicated S. aureus bloodstream infection. Leptin may be protective against the development of a complicated S. aureus bloodstream infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lindsay JA, Holden MT: Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus. Funct Integr Genomics. 2006, 6 (3): 186-201. 10.1007/s10142-005-0019-7.CrossRefPubMed Lindsay JA, Holden MT: Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus. Funct Integr Genomics. 2006, 6 (3): 186-201. 10.1007/s10142-005-0019-7.CrossRefPubMed
2.
go back to reference Fowler VG, Nelson CL, McIntyre LM, Kreiswirth BN, Monk A, Archer GL, Federspiel J, Naidich S, Remortel B, Rude T, Brown P, Reller LB, Corey GR, Gill SR: Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis. 2007, 196 (5): 738-747. 10.1086/520088.CrossRefPubMed Fowler VG, Nelson CL, McIntyre LM, Kreiswirth BN, Monk A, Archer GL, Federspiel J, Naidich S, Remortel B, Rude T, Brown P, Reller LB, Corey GR, Gill SR: Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis. 2007, 196 (5): 738-747. 10.1086/520088.CrossRefPubMed
3.
go back to reference Takata T, Miyazaki M, Futo M, Hara S, Shiotsuka S, Kamimura H, Yoshimura H, Matsunaga A, Nishida T, Ishikura H, Tamura K, Tsuji BT: Presence of both heterogeneous vancomycin-intermediate resistance and beta-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection. Scand J Infect Dis. 2013, 45 (3): 203-212. 10.3109/00365548.2012.723221.CrossRefPubMed Takata T, Miyazaki M, Futo M, Hara S, Shiotsuka S, Kamimura H, Yoshimura H, Matsunaga A, Nishida T, Ishikura H, Tamura K, Tsuji BT: Presence of both heterogeneous vancomycin-intermediate resistance and beta-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection. Scand J Infect Dis. 2013, 45 (3): 203-212. 10.3109/00365548.2012.723221.CrossRefPubMed
4.
go back to reference Verkaik NJ, Dauwalder O, Antri K, Boubekri I, de Vogel CP, Badiou C, Bes M, Vandenesch F, Tazir M, Hooijkaas H, Verbrugh HA, van Belkum A, Etienne J, Lina G, Ramdani-Bouguessa N, van Wamel WJ: Immunogenicity of toxins during Staphylococcus aureus infection. Clin Infect Dis. 2010, 50 (1): 61-68. 10.1086/648673.CrossRefPubMed Verkaik NJ, Dauwalder O, Antri K, Boubekri I, de Vogel CP, Badiou C, Bes M, Vandenesch F, Tazir M, Hooijkaas H, Verbrugh HA, van Belkum A, Etienne J, Lina G, Ramdani-Bouguessa N, van Wamel WJ: Immunogenicity of toxins during Staphylococcus aureus infection. Clin Infect Dis. 2010, 50 (1): 61-68. 10.1086/648673.CrossRefPubMed
5.
go back to reference Santos SS, Brunialti MK, Rigato O, Machado FR, Silva E, Salomao R: Generation of nitric oxide and reactive oxygen species by neutrophils and monocytes from septic patients and association with outcomes. Shock. 2012, 38 (1): 18-23. 10.1097/SHK.0b013e318257114e.CrossRefPubMed Santos SS, Brunialti MK, Rigato O, Machado FR, Silva E, Salomao R: Generation of nitric oxide and reactive oxygen species by neutrophils and monocytes from septic patients and association with outcomes. Shock. 2012, 38 (1): 18-23. 10.1097/SHK.0b013e318257114e.CrossRefPubMed
6.
go back to reference Fowler VJ, Justice A, Moore C, Benjamin DK, Woods CW, Campbell S, Reller LB, Corey GR, Day NP, Peacock SJ: Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005, 40 (5): 695-703. 10.1086/427806.CrossRefPubMed Fowler VJ, Justice A, Moore C, Benjamin DK, Woods CW, Campbell S, Reller LB, Corey GR, Day NP, Peacock SJ: Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005, 40 (5): 695-703. 10.1086/427806.CrossRefPubMed
7.
go back to reference Wang JE, Jorgensen PF, Almlof M, Thiemermann C, Foster SJ, Aasen AO, Solberg R: Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun. 2000, 68 (7): 3965-3970. 10.1128/IAI.68.7.3965-3970.2000.CrossRefPubMedPubMedCentral Wang JE, Jorgensen PF, Almlof M, Thiemermann C, Foster SJ, Aasen AO, Solberg R: Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun. 2000, 68 (7): 3965-3970. 10.1128/IAI.68.7.3965-3970.2000.CrossRefPubMedPubMedCentral
8.
go back to reference Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ: Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002, 137 (10): 791-797. 10.7326/0003-4819-137-10-200211190-00007.CrossRefPubMed Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ: Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002, 137 (10): 791-797. 10.7326/0003-4819-137-10-200211190-00007.CrossRefPubMed
9.
go back to reference Peres AG, Madrenas J: The broad landscape of immune interactions with Staphylococcus aureus: from commensalism to lethal infections. Burns. 2013, 39 (3): 380-388. 10.1016/j.burns.2012.12.008.CrossRefPubMed Peres AG, Madrenas J: The broad landscape of immune interactions with Staphylococcus aureus: from commensalism to lethal infections. Burns. 2013, 39 (3): 380-388. 10.1016/j.burns.2012.12.008.CrossRefPubMed
10.
go back to reference Yao L, Bengualid V, Lowy FD, Gibbons JJ, Hatcher VB, Berman JW: Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression. Infect Immun. 1995, 63 (5): 1835-1839.PubMedPubMedCentral Yao L, Bengualid V, Lowy FD, Gibbons JJ, Hatcher VB, Berman JW: Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression. Infect Immun. 1995, 63 (5): 1835-1839.PubMedPubMedCentral
11.
go back to reference Strindhall J, Lindgren PE, Lofgren S, Kihlstrom E: Clinical isolates of Staphylococcus aureus vary in ability to stimulate cytokine expression in human endothelial cells. Scand J Immunol. 2005, 61 (1): 57-62. 10.1111/j.0300-9475.2005.01526.x.CrossRefPubMed Strindhall J, Lindgren PE, Lofgren S, Kihlstrom E: Clinical isolates of Staphylococcus aureus vary in ability to stimulate cytokine expression in human endothelial cells. Scand J Immunol. 2005, 61 (1): 57-62. 10.1111/j.0300-9475.2005.01526.x.CrossRefPubMed
12.
go back to reference Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH, Steckelberg J, Osmon D: Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg. 2010, 92 (11): 2102-2109. 10.2106/JBJS.I.01199.CrossRefPubMed Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH, Steckelberg J, Osmon D: Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg. 2010, 92 (11): 2102-2109. 10.2106/JBJS.I.01199.CrossRefPubMed
13.
go back to reference Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg. 1992, 215 (4): 356-362. 10.1097/00000658-199204000-00009.CrossRefPubMedPubMedCentral Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg. 1992, 215 (4): 356-362. 10.1097/00000658-199204000-00009.CrossRefPubMedPubMedCentral
14.
go back to reference Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood. 1989, 74 (5): 1704-1710.PubMed Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood. 1989, 74 (5): 1704-1710.PubMed
15.
go back to reference Uusitalo-Seppala R, Koskinen P, Leino A, Peuravuori H, Vahlberg T, Rintala EM: Early detection of severe sepsis in the emergency room: diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6. Scand J Infect Dis. 2011, 43 (11-12): 883-890. 10.3109/00365548.2011.600325.CrossRefPubMed Uusitalo-Seppala R, Koskinen P, Leino A, Peuravuori H, Vahlberg T, Rintala EM: Early detection of severe sepsis in the emergency room: diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6. Scand J Infect Dis. 2011, 43 (11-12): 883-890. 10.3109/00365548.2011.600325.CrossRefPubMed
16.
go back to reference Feezor RJ, Oberholzer C, Baker HV, Novick D, Rubinstein M, Moldawer LL, Pribble J, Souza S, Dinarello CA, Ertel W, Oberholzer A: Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun. 2003, 71 (10): 5803-5813. 10.1128/IAI.71.10.5803-5813.2003.CrossRefPubMedPubMedCentral Feezor RJ, Oberholzer C, Baker HV, Novick D, Rubinstein M, Moldawer LL, Pribble J, Souza S, Dinarello CA, Ertel W, Oberholzer A: Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun. 2003, 71 (10): 5803-5813. 10.1128/IAI.71.10.5803-5813.2003.CrossRefPubMedPubMedCentral
17.
go back to reference Jekarl DW, Lee SY, Lee J, Park YJ, Kim Y, Park JH, Wee JH, Choi SP: Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis. 2013, 75 (4): 342-347. 10.1016/j.diagmicrobio.2012.12.011.CrossRefPubMed Jekarl DW, Lee SY, Lee J, Park YJ, Kim Y, Park JH, Wee JH, Choi SP: Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis. 2013, 75 (4): 342-347. 10.1016/j.diagmicrobio.2012.12.011.CrossRefPubMed
18.
go back to reference Venge J, Lampinen M, Hakansson L, Rak S, Venge P: Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol. 1996, 97 (5): 1110-1115. 10.1016/S0091-6749(96)70265-8.CrossRefPubMed Venge J, Lampinen M, Hakansson L, Rak S, Venge P: Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol. 1996, 97 (5): 1110-1115. 10.1016/S0091-6749(96)70265-8.CrossRefPubMed
19.
go back to reference Megyeri K, Mandi Y, Degre M, Rosztoczy I: Induction of cytokine production by different Staphylococcal strains. Cytokine. 2002, 19 (4): 206-212. 10.1006/cyto.2002.0876.CrossRefPubMed Megyeri K, Mandi Y, Degre M, Rosztoczy I: Induction of cytokine production by different Staphylococcal strains. Cytokine. 2002, 19 (4): 206-212. 10.1006/cyto.2002.0876.CrossRefPubMed
20.
go back to reference Kanangat S, Postlethwaite A, Cholera S, Williams L, Schaberg D: Modulation of virulence gene expression in Staphylococcus aureus by interleukin-1beta: novel implications in bacterial pathogenesis. Microbes Infect. 2007, 9 (3): 408-415. 10.1016/j.micinf.2006.12.018.CrossRefPubMed Kanangat S, Postlethwaite A, Cholera S, Williams L, Schaberg D: Modulation of virulence gene expression in Staphylococcus aureus by interleukin-1beta: novel implications in bacterial pathogenesis. Microbes Infect. 2007, 9 (3): 408-415. 10.1016/j.micinf.2006.12.018.CrossRefPubMed
21.
go back to reference Arnalich F, Lopez J, Codoceo R, Jimnez M, Madero R, Montiel C: Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock. J Infect Dis. 1999, 180 (3): 908-911. 10.1086/314963.CrossRefPubMed Arnalich F, Lopez J, Codoceo R, Jimnez M, Madero R, Montiel C: Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock. J Infect Dis. 1999, 180 (3): 908-911. 10.1086/314963.CrossRefPubMed
22.
go back to reference Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, Chrousos GP: Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab. 1998, 83 (1): 280-283. 10.1210/jcem.83.1.4610.CrossRefPubMed Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, Chrousos GP: Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab. 1998, 83 (1): 280-283. 10.1210/jcem.83.1.4610.CrossRefPubMed
23.
go back to reference Shapiro NI, Khankin EV, Van Meurs M, Shih SC, Lu S, Yano M, Castro PR, Maratos-Flier E, Parikh SM, Karumanchi SA, Yano K: Leptin exacerbates sepsis-mediated morbidity and mortality. J Immunol. 2010, 185 (1): 517-524. 10.4049/jimmunol.0903975.CrossRefPubMedPubMedCentral Shapiro NI, Khankin EV, Van Meurs M, Shih SC, Lu S, Yano M, Castro PR, Maratos-Flier E, Parikh SM, Karumanchi SA, Yano K: Leptin exacerbates sepsis-mediated morbidity and mortality. J Immunol. 2010, 185 (1): 517-524. 10.4049/jimmunol.0903975.CrossRefPubMedPubMedCentral
24.
go back to reference Hultgren OH, Tarkowski A: Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration. Arthritis Res. 2001, 3 (6): 389-394. 10.1186/ar332.CrossRefPubMedPubMedCentral Hultgren OH, Tarkowski A: Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration. Arthritis Res. 2001, 3 (6): 389-394. 10.1186/ar332.CrossRefPubMedPubMedCentral
25.
go back to reference Vaudaux PE, Monzillo V, Francois P, Lew DP, Foster TJ, Berger-Bachi B: Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesins. Antimicrob Agents Chemother. 1998, 42 (3): 564-570.PubMedPubMedCentral Vaudaux PE, Monzillo V, Francois P, Lew DP, Foster TJ, Berger-Bachi B: Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesins. Antimicrob Agents Chemother. 1998, 42 (3): 564-570.PubMedPubMedCentral
26.
go back to reference Otto M: Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol. 2010, 64: 143-162. 10.1146/annurev.micro.112408.134309.CrossRefPubMed Otto M: Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol. 2010, 64: 143-162. 10.1146/annurev.micro.112408.134309.CrossRefPubMed
Metadata
Title
Cytokine responses to Staphylococcus aureusbloodstream infection differ between patient cohorts that have different clinical courses of infection
Authors
Sinead McNicholas
Alida Fe Talento
Joanne O’Gorman
Margaret M Hannan
Maureen Lynch
Catherine M Greene
Hilary Humphreys
Deirdre Fitzgerald-Hughes
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-014-0580-6

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.